Oncothyreon HomeContactSite MapGlossary
Investors
 
Stock Information
NASDAQ: ONTY
$4.98  
Mar 11, 2010
3:59 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Corporate Governance

The Board of Directors of Oncothyreon (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Corporate Governance View
Audit Committee Charter   PDF   31.0 KB Add to Briefcase
Corporate Governance and Nominating Committee Charter   PDF   17.2 KB Add to Briefcase
Compensation Committee Charter   PDF   22.5 KB Add to Briefcase
Code of Ethics and Business Conduct   PDF  110.9 KB Add to Briefcase
Code of Ethics for Financial Officers   PDF   20.1 KB Add to Briefcase
Executive Summary of Public Disclosure Policy   PDF   57.7 KB Add to Briefcase
Corporate Governance Principles   PDF   31.2 KB Add to Briefcase


Add to Briefcase = add file to Briefcase

return to top ^

About Oncothyreon | Pipeline | Clinical Trials | Business Development | Investors | News & Events